Crossmark

Correction: A phase 3 study of the efficacy and safety of avatrombopag in Japanese adults with chronic immune thrombocytopenia

Crossref DOI link: https://doi.org/10.1007/s12185-025-04054-5

Published Online: 2025-08-19

Published Print: 2025-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yamaguchi, Hiroki https://orcid.org/0000-0002-0571-7495
Iino, Masaki https://orcid.org/0000-0002-3471-0890
Kowata, Shugo

Yamamoto, Ryusuke

Yamanouchi, Jun

Imamura, Yutaka

Kirito, Keita

Yokoyama, Kenji https://orcid.org/0000-0003-2452-7248
Ito, Tomoki https://orcid.org/0000-0001-5419-9156
Ishikawa, Tatsunori

Shiratsuchi, Motoaki https://orcid.org/0000-0002-0403-0122
Tomiyama, Yoshiaki https://orcid.org/0000-0001-7645-0989
Kamiya, Harumi

Zhang, Jessica

Jamieson, Brian D.
License Information

Text and Data Mining valid from 2025-08-19

Version of Record valid from 2025-08-19
More Information

Article History

First Online: 19 August 2025